Clinically Relevant Transporter DDIs

The following charts show a partial list of compounds that have been implicated in transporter-based clinically relevant drug-drug interactions as either a substrate or inhibitor.

P-gp

 

Transporter	Perpetrators/Inhibitors	Victims/Substrates
P-gp	Clarithromycin Cyclosporine Erythromycin Itraconazole Quinidine Ritonavir Telithromycin Verapamil	Aliskiren Digoxin Docetaxel Fexofenadine Paclitaxel Ritonavir Talinolol Vinblastine

 

BCRP

 

Transporter	Perpetrators/Inhibitors	Victims/Substrates
BCRP	Elacridar (GF120918)	Pitavastatin Rosuvastatin Topotecan

 

OATP1B1

 

Transporter	Perpetrators/Inhibitors	Victims/Substrates
OATP1B1	Atazanavir Clarithromycin Cyclosporine Gemfibrozil Glibenclamide Lopinavir Rifampin	Bosentan Cerivastatin Pravastatin Rifampin Rosuvastatin Simvastatin Valsartan

 

OATP1B3

 

Transporter	Perpetrators/Inhibitors	Victims/Substrates
OATP1B3	Atazanavir Clarithromycin Cyclosporine Gemfibrozil Lopinavir Rifampin	Bosentan Paclitaxel Pravastatin Rifampin Rosuvastatin Valsartan

 

OATP2B1

 

Transporter	Perpetrators/Inhibitors	Victims/Substrates
OATP2B1	Cyclosporine Gemfibrozil Quercetin Grapefruit juice Orange juice	Aliskiren Atorvastatin Pravastatin Pitavastatin Rosuvastatin

 

OATP1A2

 

Transporter	Perpetrators/Inhibitors	Victims/Substrates
OATP1A2	Verapamil Naringin Quercetin Grapefruit juice Orange juice	Atenolol Celiprolol Ciprofloxacin Fexofenadine Pravastatin

 

OAT1

 

Transporter	Perpetrators/Inhibitors	Victims/Substrates
OAT1	Indomethacin Mycophenolate Olmesartan Probenecid	Adefovir Captopril Cidofovir Furosemide

 

OAT3

 

Transporter	Perpetrators/Inhibitors	Victims/Substrates
OAT3	Gemfibrozil Indomethacin Mycophenolate Olmesartan Probenecid Salicylate	Benzylpenicillin Cefotiam Furosemide Methotrexate Olmesartan Pravastatin

 

OCT2

 

Transporter	Perpetrators/Inhibitors	Victims/Substrates
OCT2	Bisoprolol Carvedilol Cimetidine Procainamide Ranitidine Trimethoprim	Amatadine Cimetidine Cisplatin Lamivudine Metformin Ranitidine

 

MATE1

 

Transporter	Perpetrators/Inhibitors	Victims/Substrates
MATE1	Cimetidine Pyrmethamine Quinidine Rapamycin	Cephalexin Cimetidine Metformin Procainamide

 
 
   

How Can We Help You?

<< Drug Transporters
ABC (Efflux) Transporters
SLC (Uptake) Transporters
 

• Analytical Services
  • Metabolite ID & Characterization
  • Small-molecule bioanalysis
• Biologic Services
• Consulting
• Discovery Plus Screening Suite
  • Plasma Protein Binding
  • Metabolic Stability
  • CYP Inhibition
  • Enzyme Induction
  • Drug Transporter Inhibition
  • Cell-Based Permeability
• Drug Metabolism
  • Metabolic Stability
  • Metabolite ID & Characterization
    • Metabolite Production
  • Plasma Protein & Covalent Binding
  • Reaction Phenotyping
  • Species Comparison
  • Non-CYP Metabolism
• Drug Transporters
  • ABC (Efflux) Transporters
    • Transwell Assay Design
    • Vesicle Assay Design
  • SLC (Uptake) Transporters
    • Uptake Assay Design
  • Clinically Relevant Transporter DDIs
• Enzyme Induction
  • In Vitro CYP Induction (Definitive)
  • In Vitro UGT Induction (Definitive)
  • In Vitro Discovery Plus Induction (Screening)
  • Ex Vivo CYP and UGT Enzyme Induction
  • Cytotoxicity
• Enzyme Inhibition
  • CYP Inhibition
    • Follow-up Studies
  • Discovery Plus Inhibition Screening
  • UGT Inhibition
• In Vivo ADME
  • Pharmacokinetics
  • Radio-Labeled Synthesis
    • Metabolite Production
  • Whole-Body Autoradiography
• Lysosomal Trapping
• Pharmacology / Receptor Binding
  • RadioReceptor Assay (RRA)
• Protein Binding
• API Manufacturing
• Services Catalog